![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shufeng Yi, Fan Yang, Cunle Jie & Guiqin Zhang. (2019) A novel strategy to the formulation of carmustine and bioactive nanoparticles co-loaded PLGA biocomposite spheres for targeting drug delivery to glioma treatment and nursing care. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3438-3447.
Read now
Read now
Karan Gulati, Moom Sinn Aw & Dusan Losic. (2012) Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain. International Journal of Nanomedicine 7, pages 2069-2076.
Read now
Read now
Articles from other publishers (43)
Xi Yang, Lingnan Zheng, Ling Gao, Lingyun Zhang, Jinlan He, YuanFeng Wei, Jia You, Huawei Li, Cheng Yi & Han Luo. (2023) A Local Strategy Toward Concurrent Chemoradiotherapy Based on Fibrin Gel for Postsurgical Cancer Treatment. International Journal of Radiation Oncology*Biology*Physics 116:5, pages 1190-1201.
Crossref
Crossref
Soham D. Parikh, Wenhu Wang, M. Tyler Nelson, Courtney E. W. Sulentic & Sharmila M. Mukhopadhyay. (2023) Bioinspired Hierarchical Carbon Structures as Potential Scaffolds for Wound Healing and Tissue Regeneration Applications. Nanomaterials 13:11, pages 1791.
Crossref
Crossref
Margarethe Hauck, Jan Dittmann, Berit Zeller-Plumhoff, Roshani Madurawala, Dana Hellmold, Carolin Kubelt, Michael Synowitz, Janka Held-Feindt, Rainer Adelung, Stephan Wulfinghoff & Fabian Schütt. (2022) Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release. Pharmaceutics 14:4, pages 777.
Crossref
Crossref
Toshihiko Iuchi, Akihiro Inoue, Yuichi Hirose, Motohiro Morioka, Keishi Horiguchi, Atsushi Natsume, Yoshiki Arakawa, Koichi Iwasaki, Minoru Fujiki, Toshihiro Kumabe & Yukinori Sakata. (2022) Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. Neuro-Oncology Advances 4:1.
Crossref
Crossref
Güliz Ak, Ayşe Ünal, Tuğba Karakayalı, Buket Özel, Nur Selvi Günel & Şenay Hamarat Şanlıer. (2021) Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture. Colloids and Surfaces B: Biointerfaces 206, pages 111946.
Crossref
Crossref
Majed Alghamdi, Mark Gumbleton & Ben Newland. (2021) Local delivery to malignant brain tumors: potential biomaterial-based therapeutic/adjuvant strategies. Biomaterials Science 9:18, pages 6037-6051.
Crossref
Crossref
Luiza C.S. Erthal, Oliviero L. Gobbo & Eduardo Ruiz-Hernandez. (2021) Biocompatible copolymer formulations to treat glioblastoma multiforme. Acta Biomaterialia 121, pages 89-102.
Crossref
Crossref
Ryo NISHIKAWA, Hisayuki IWATAYukinori SAKATAKenzo MURAMOTOToshiyuki MATSUOKA. (2021) Safety of Gliadel Implant for Malignant Glioma: Report of Postmarketing Surveillance in Japan. Neurologia medico-chirurgica 61:9, pages 536-548.
Crossref
Crossref
Ran Li, Thomas S. C. Ng, Michelle A. Garlin, Ralph Weissleder & Miles A. Miller. (2020) Understanding the In Vivo Fate of Advanced Materials by Imaging. Advanced Functional Materials 30:37, pages 1910369.
Crossref
Crossref
Stephanie J. Franks, Kate Firipis, Rita Ferreira, Katherine M. Hannan, Richard J. Williams, Ross D. Hannan & David R. Nisbet. (2020) Harnessing the self-assembly of peptides for the targeted delivery of anti-cancer agents. Materials Horizons 7:8, pages 1996-2010.
Crossref
Crossref
Soham D. Parikh, Soham Dave, Luping Huang, Wenhu Wang, Sharmila M. Mukhopadhyay & Debra A. Mayes. (2020) Multi-walled carbon nanotube carpets as scaffolds for U87MG glioblastoma multiforme cell growth. Materials Science and Engineering: C 108, pages 110345.
Crossref
Crossref
Enas Abu-Qudais, Balakumar Chandrasekaran, Sara Samarneh & Ghadir Kassab. 2020. Integrative Nanomedicine for New Therapies. Integrative Nanomedicine for New Therapies
321
356
.
Mengnan Zhao, Elia Bozzato, Nicolas Joudiou, Sina Ghiassinejad, Fabienne Danhier, Bernard Gallez & Véronique Préat. (2019) Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection. Journal of Controlled Release 309, pages 72-81.
Crossref
Crossref
Akansha Jalota, Mukesh Kumar, Bhudev C. Das, Ajay K. Yadav, Kunzang Chosdol & Subrata Sinha. (2018) A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells. Oncotarget 9:26, pages 18351-18366.
Crossref
Crossref
Zerrin Ozkose Satirlar & Gozde Inan. 2018. Obstetric Anesthesia for Co-morbid Conditions. Obstetric Anesthesia for Co-morbid Conditions
99
116
.
Rami Walid Chakroun, Pengcheng Zhang, Ran Lin, Paula Schiapparelli, Alfredo Quinones‐Hinojosa & Honggang Cui. (2017) Nanotherapeutic systems for local treatment of brain tumors. WIREs Nanomedicine and Nanobiotechnology 10:1.
Crossref
Crossref
Ana Miranda, María Blanco-Prieto, João Sousa, Alberto Pais & Carla Vitorino. (2017) Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches. International Journal of Pharmaceutics 531:1, pages 372-388.
Crossref
Crossref
Shinji Shimato, Toshihisa Nishizawa, Tomotaka Ohshima, Tasuku Imai, Shunsaku Goto, Taiki Yamamoto & Kyozo Kato. (2016) Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution. World Neurosurgery 90, pages 340-347.
Crossref
Crossref
Seema Shroff, Rajan Jain, Souhel Najjar, Fawaz Alotaibi & David Zagzag. 2015. The Blood-Brain Barrier in Health and Disease, Volume Two. The Blood-Brain Barrier in Health and Disease, Volume Two
278
298
.
M. Balducci, B. Diletto, S. Chiesa, G.R. D’Agostino, M.A. Gambacorta, M. Ferro, C. Colosimo, G. Maira, C. Anile & V. Valentini. (2014) Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastomaNiedrigdosierte fraktionierte Strahlentherapie und gleichzeitige Chemotherapie bei rezidiviertem oder progredientem Glioblastom. Strahlentherapie und Onkologie 190:4, pages 370-376.
Crossref
Crossref
Hikaru Sasaki. (2014) Recent Advance and Updates in Chemotherapy for Glioma. Japanese Journal of Neurosurgery 23:7, pages 547-558.
Crossref
Crossref
David Stepensky. 2014. Focal Controlled Drug Delivery. Focal Controlled Drug Delivery
149
166
.
Gao-Feng Xu & Wan-Fu Xie. (2013) Effect of ERBB2 expression on invasiveness of glioma TJ905 cells. Asian Pacific Journal of Tropical Medicine 6:12, pages 964-967.
Crossref
Crossref
Babak Kateb & John HeissJoseph Cheatle & Michele Aizenberg. 2013. The Textbook of Nanoneuroscience and Nanoneurosurgery. The Textbook of Nanoneuroscience and Nanoneurosurgery
381
394
.
Ramsey A Foty. (2013) Tumor cohesion and glioblastoma cell dispersal. Future Oncology 9:8, pages 1121-1132.
Crossref
Crossref
Kashif Jilani & Florian Lang. (2013) Carmustine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane. Toxins 5:4, pages 703-716.
Crossref
Crossref
Kevin P. Rice, Edmund J. Klinkerch, Scott A. Gerber, Tyler R. Schleicher, Tara J. Kraus & Christopher M. Buros. (2012) Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine. Molecular and Cellular Biochemistry 370:1-2, pages 199-207.
Crossref
Crossref
Jang Il Kim, Bora Kim, ChangJu Chun, Seung Hoon Lee & Soo-Chang Song. (2012) MRI-monitored long-term therapeutic hydrogel system for brain tumors without surgical resection. Biomaterials 33:19, pages 4836-4842.
Crossref
Crossref
S. Ulmer, K. Spalek, A. Nabavi, S. Schultka, H. M. Mehdorn, S. Kesari & L. Dorner. (2012) Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma. Neuro-Oncology 14:4, pages 482-490.
Crossref
Crossref
Gregorio Catalán-Uribarrena, Gaizka Bilbao-Barandica, Iñigo Pomposo-Gaztelu, José Undabeitia-Huertas, Edurne Ruiz de Gopegui-Ruiz, Lara Galbarriatu-Gutiérrez, Manuel Canales-Llantada, Jon Aurrecoechea-Obieta, Alfonso Igartua-Azkune & Guillermo Carbayo-Lozano. (2011) Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Acta Neurochirurgica 154:2, pages 211-222.
Crossref
Crossref
Nazila Kamaly, Zeyu Xiao, Pedro M. Valencia, Aleksandar F. Radovic-Moreno & Omid C. Farokhzad. (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chemical Society Reviews 41:7, pages 2971.
Crossref
Crossref
Douglas L. Stofko, Robert J. Weil & Steven A. Toms. 2012. Central Nervous System Metastasis, the Biological Basis and Clinical Considerations. Central Nervous System Metastasis, the Biological Basis and Clinical Considerations
109
132
.
C. Wischke & S. P. Schwendeman. 2012. Fundamentals and Applications of Controlled Release Drug Delivery. Fundamentals and Applications of Controlled Release Drug Delivery
171
228
.
Annelies Van Dycke, Robrecht Raedt, Kristl Vonck & Paul Boon. (2011) Local delivery strategies in epilepsy; a focus on adenosine. Seizure 20:5, pages 376-382.
Crossref
Crossref
Luca Persano, Elena Rampazzo, Alessandro Della Puppa, Francesca Pistollato & Giuseppe Basso. (2011) The Three-Layer Concentric Model of Glioblastoma: Cancer Stem Cells, Microenvironmental Regulation, and Therapeutic Implications. The Scientific World JOURNAL 11, pages 1829-1841.
Crossref
Crossref
Maximilian Niyazi, Axel Siefert, Silke Birgit Schwarz, Ute Ganswindt, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn & Claus Belka. (2011) Therapeutic options for recurrent malignant glioma. Radiotherapy and Oncology 98:1, pages 1-14.
Crossref
Crossref
P.-Y. Chen, H.-L. Liu, M.-Y. Hua, H.-W. Yang, C.-Y. Huang, P.-C. Chu, L.-A. Lyu, I.-C. Tseng, L.-Y. Feng, H.-C. Tsai, S.-M. Chen, Y.-J. Lu, J.-J. Wang, T.-C. Yen, Y.-H. Ma, T. Wu, J.-P. Chen, J.-I. Chuang, J.-W. Shin, C. Hsueh & K.-C. Wei. (2010) Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro-Oncology 12:10, pages 1050-1060.
Crossref
Crossref
Steffen Baltes, Ina Freund, Andrew L. Lewis, Ingo Nolte & Thomas Brinker. (2010) Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model. Journal of Materials Science: Materials in Medicine 21:4, pages 1393-1402.
Crossref
Crossref
P. Morales‐Ramírez, T. Vallarino‐Kelly & V.L. Cruz‐Vallejo. (2009) Effect of O6‐chloroethylguanine DNA lesions on the kinetics and mechanism of micronucleus induction in vivo. Environmental and Molecular Mutagenesis 51:3, pages 236-242.
Crossref
Crossref
Anne Balossier, Lutz Dörner, Evelyne Emery, Oliver Heese, H. Maximilian Mehdorn, Philippe Menei & Jagmohan Singh. (2010) Incorporating BCNU Wafers into Malignant Glioma Treatment. Clinical Drug Investigation 30:3, pages 195-204.
Crossref
Crossref
Jan Drappatz, Andrew D. Norden & Patrick Y. Wen. 2009. Therapeutic Ribonucleic Acids in Brain Tumors. Therapeutic Ribonucleic Acids in Brain Tumors
355
382
.
Hemant Sarin, Ariel S Kanevsky, Haitao Wu, Kyle R Brimacombe, Steve H Fung, Alioscka A Sousa, Sungyoung Auh, Colin M Wilson, Kamal Sharma, Maria A Aronova, Richard D Leapman, Gary L Griffiths & Matthew D Hall. (2008) Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. Journal of Translational Medicine 6:1.
Crossref
Crossref
Tariq Parvez. (2008) Present Trend in the Primary Treatment of Aggressive Malignant Glioma: Glioblastoma Multiforme. Technology in Cancer Research & Treatment 7:3, pages 241-248.
Crossref
Crossref